Literature DB >> 17342952

Combining adaptive designs with control of the false discovery rate--a generalized definition for a global p-value.

Anja Victor1, Gerhard Hommel.   

Abstract

When combining adaptive designs with control of the False Discovery Rate one has to keep in mind that the most frequently used procedure for controlling the False Discovery Rate--the explorative Simes procedure--is a stepwise multiple testing procedure. At the interim analysis of an adaptive design it is however not yet known what the boundaries for rejection of hypotheses in the final analysis will be as these boundaries depend on the size of the final p-values. Therefore classical adaptive designs with a predefined stopping criterion for early rejection of hypotheses are not well suited. We propose a generalized definition of a global p-value for a two-stage adaptive design permitting a flexible decision for stopping at the interim analysis. By means of a simulation study in the field of genetic epidemiology we illustrate how applying such a two-stage design can reduce costs.

Mesh:

Year:  2007        PMID: 17342952     DOI: 10.1002/bimj.200510311

Source DB:  PubMed          Journal:  Biom J        ISSN: 0323-3847            Impact factor:   2.207


  4 in total

1.  Post hoc power estimation in large-scale multiple testing problems.

Authors:  Sonja Zehetmayer; Martin Posch
Journal:  Bioinformatics       Date:  2010-02-25       Impact factor: 6.937

2.  Twenty-five years of confirmatory adaptive designs: opportunities and pitfalls.

Authors:  Peter Bauer; Frank Bretz; Vladimir Dragalin; Franz König; Gernot Wassmer
Journal:  Stat Med       Date:  2015-03-16       Impact factor: 2.373

3.  False discovery rate control in two-stage designs.

Authors:  Sonja Zehetmayer; Martin Posch
Journal:  BMC Bioinformatics       Date:  2012-05-06       Impact factor: 3.169

4.  Sequential interim analyses of survival data in DNA microarray experiments.

Authors:  Andreas Leha; Tim Beissbarth; Klaus Jung
Journal:  BMC Bioinformatics       Date:  2011-04-29       Impact factor: 3.169

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.